REFERENCES
1.Rosique-Esteban, N., et al., Dietary Magnesium and Cardiovascular Disease: A Review with Emphasis in Epidemiological Studies. Nutrients, 2018. 10(2): p. 168.
2.Seelig, M.S., Magnesium Deficiency in the Pathogenesis of Disease. 1980: Springer US.
3.Chandrasekaran, N.C., et al., Effects of magnesium deficiency--more than skin deep. Exp Biol Med (Maywood), 2014. 239(10): p. 1280-91.
4.Fawcett, W.J., E.J. Haxby, and D.A. Male, Magnesium: physiology and pharmacology. BJA: British Journal of Anaesthesia, 1999. 83(2): p. 302-320.
5.Reddy, P. and L.R. Edwards, Magnesium Supplementation in Vitamin D Deficiency. Am J Ther, 2019. 26(1): p. e124-e132.
6.Andralojc, J., Pollack, G.H. Cells, gels and the engines of life. (A new, unifying approach to cell function) 1st edn. Annals of Botany, 2003. 91(3): p. 404-405.
7.Dibaba, D.T., et al., The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr, 2017. 106(3): p. 921-929.
8.Maier, J.A.M., et al., Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004. 1689(1): p. 13-21.
9.Seelig, M.S. and A. Rosanoff, The magnesium factor. 2003, New York: Avery.
10.Kostov, K. and L. Halacheva, Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension. International journal of molecular sciences, 2018. 19(6): p. 1724.
11.Teragawa, H., et al., Magnesium causes nitric oxide independent coronary artery vasodilation in humans. Heart (British Cardiac Society), 2001. 86(2): p. 212-216.
12.Kolte, D., et al., Role of Magnesium in Cardiovascular Diseases. Vol. 22. 2014. 182-192.
13.Shechter, M., et al., Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease. Am Heart J, 2000. 140(2): p. 212-8.
14.Hansen, B.-A. and Ø. Bruserud, Hypomagnesemia in critically ill patients. Journal of Intensive Care, 2018. 6(1): p. 21.
15.Chandrasekaran, N., Effect of topical magnesium application on epidermal integrity and barrier function 2016, The University of Queensland. p. 84.
16.Toft, G., H.B. Ravn, and V.E. Hjortdal, Intravenously and Topically Applied Magnesium in the Prevention of Arterial Thrombosis<sup>☆</sup>. Thrombosis Research. 99(1): p. 61-69.
17.Kass, L., et al., Effect of transdermal magnesium cream on serum and urinary magnesium levels in humans: A pilot study. PloS one, 2017. 12(4): p. e0174817-e0174817.
18.Sang-ngern, M., et al., Preliminary study of transdermal permeation of magnesium cream formulations across skin. 2012.